Cooper Companies (NASDAQ:COO) Earns "Hold (C-)" Rating from Weiss Ratings

Key Points

• Cooper Companies (NASDAQ:COO) received a restated "hold (C-)" rating from Weiss Ratings, amidst a mixed bag of ratings from other brokerages, including a recent "sell" from Goldman Sachs and "buy" upgrades from UBS and BNP Paribas.
• The stock price of Cooper Companies is currently trading at $70.26, up 1.8%, with a 1-year low of $61.78 and a high of $109.37, reflecting volatility in its market performance.
• Cooper Companies plans to initiate a $2 billion share buyback, allowing repurchases of up to 15.4% of its shares, indicating that management believes the stock is undervalued.

Cooper Companies (NASDAQ:COO - Get Free Report)'s stock had its "hold (c-)" rating restated by Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

A number of other brokerages also recently issued reports on COO. The Goldman Sachs Group set a $64.00 price target on Cooper Companies and gave the stock a "sell" rating in a research report on Wednesday, October 1st. UBS Group upgraded Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Mizuho lowered their price target on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. Finally, Piper Sandler cut their price objective on Cooper Companies from $105.00 to $83.00 and set an "overweight" rating for the company in a research report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $84.75.

Cooper Companies Trading Up 1.8%

Shares of COO traded up $1.24 during midday trading on Wednesday, hitting $70.26. The stock had a trading volume of 1,770,317 shares, compared to its average volume of 2,692,000. Cooper Companies has a 1 year low of $61.78 and a 1 year high of $109.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The stock's 50 day moving average is $69.50 and its 200 day moving average is $73.93. The firm has a market cap of $13.97 billion, a PE ratio of 34.61, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the firm posted $0.96 earnings per share. The business's revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share buyback plan on Wednesday, September 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its stock is undervalued.

Insider Activity

In other Cooper Companies news, Director Lawrence Erik Kurzius acquired 2,000 shares of the firm's stock in a transaction that occurred on Monday, September 29th. The shares were purchased at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the completion of the acquisition, the director owned 5,777 shares of the company's stock, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Gerard H. Warner III purchased 1,450 shares of the stock in a transaction dated Friday, September 5th. The shares were acquired at an average price of $69.23 per share, with a total value of $100,383.50. Following the completion of the acquisition, the chief operating officer owned 18,319 shares in the company, valued at approximately $1,268,224.37. This trade represents a 8.60% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 17,975 shares of company stock valued at $1,216,346 in the last quarter. Insiders own 1.98% of the company's stock.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Cooper Companies by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company's stock valued at $1,725,963,000 after acquiring an additional 421,423 shares during the period. State Street Corp increased its stake in Cooper Companies by 1.2% during the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company's stock worth $616,227,000 after purchasing an additional 104,910 shares during the period. Geode Capital Management LLC lifted its position in shares of Cooper Companies by 2.5% during the second quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company's stock worth $368,893,000 after purchasing an additional 127,907 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Cooper Companies by 3.4% in the first quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company's stock valued at $436,681,000 after purchasing an additional 172,485 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Cooper Companies by 17.0% in the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after purchasing an additional 686,751 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.